The deal priced below last closing price of $17.66. Jefferies and Leerink are acting as joint book running managers for the offering.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TVTX:
- Travere Therapeutics announces common stock offering, no amount given
- Travere Therapeutics price target raised to $27 from $23 at Scotiabank
- Travere Therapeutics price target raised to $20 from $18 at Barclays
- Travere Therapeutics Boosts Sales with FILSPARI Approval
- Travere Therapeutics reports Q3 adjusted EPS (46c), consensus (68c)